Anthelmintic tablet for patients 6 years of age and older.
EGATEN™ (triclabendazole, Novartis)
Indications: treatment of fascioliasis in patients six years of age or older
Dosage:
Contraindications: known hypersensitivity to triclabendazole, other benzimidazole derivatives or any of the excipients in EGATEN
Socioeconomic Disparities Persisted Alongside Improving Vaccination Rates In US Over 11-Year Period
April 16th 2024Findings indicating that socioeconomic disparities widened gaps in vaccination timeliness signal the need for increased efforts to promote timely vaccination among children from families with lower income and those without private insurance.